Cargando…
Development of a New Highly Selective Monoclonal Antibody against Preferentially Expressed Antigen in Melanoma (PRAME) and Identification of the Target Epitope by Bio-Layer Interferometry
Background: Monoclonal antibodies (mAbs) against cancer biomarkers are key reagents in diagnosis and therapy. One such relevant biomarker is a preferentially expressed antigen in melanoma (PRAME) that is selectively expressed in many tumors. Knowing mAb’s epitope is of utmost importance for understa...
Autores principales: | Sivaccumar, Jwala Priyadarsini, Leonardi, Antonio, Iaccarino, Emanuela, Corvino, Giusy, Sanguigno, Luca, Chambery, Angela, Russo, Rosita, Valletta, Mariangela, Latino, Debora, Capasso, Domenica, Doti, Nunzianna, Ruvo, Menotti, Sandomenico, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003813/ https://www.ncbi.nlm.nih.gov/pubmed/33804612 http://dx.doi.org/10.3390/ijms22063166 |
Ejemplares similares
-
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
por: Sandomenico, Annamaria, et al.
Publicado: (2020) -
Production in Bacteria and Characterization of Engineered Humanized Fab Fragment against the Nodal Protein
por: Sivaccumar, Jwala P., et al.
Publicado: (2023) -
Recent Applications of Retro-Inverso Peptides
por: Doti, Nunzianna, et al.
Publicado: (2021) -
Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death
por: Doti, Nunzianna, et al.
Publicado: (2017) -
Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422
por: Sandomenico, Annamaria, et al.
Publicado: (2016)